Mentha Piperitae tablets (Tablets) Instructions for Use

Instructions
Dosage forms

ATC Code

A03AX (Other drugs for functional gastrointestinal disorders)

Active Substance

Peppermint oil (BP British Pharmacopoeia)

Clinical-Pharmacological Group

A drug with reflex vasodilating action

Pharmacotherapeutic Group

Spasmolytic agent of plant origin

Pharmacological Action

It is a herbal remedy. It is contained in the leaves and stems of peppermint. The essential oil is primarily composed of menthol, menthone, pinenes, dipentene, phellandrene, cineole, pulegone, jasmone, and esters of menthol with valeric and acetic acids.

It has anti-inflammatory and analgesic effects, causes local vasoconstriction, reduces skin itching, reflexively dilates blood vessels of the heart, brain, and lungs; increases appetite, reduces nausea, vomiting, hiccups, enhances salivation, intestinal peristalsis, has a carminative effect, helps reduce pressure inside the colon and reduces flatulence.

Menthol and other components of the essential oil have a spasmolytic effect on the smooth muscles of the gastrointestinal tract and urinary tract, and mildly stimulate the secretion of the digestive glands. Expectorant, mucolytic, and moderate antihypoxic effects are preserved during inhalations with peppermint oil.

It has antiseptic, deodorizing, and refreshing properties.

Indications

As part of complex therapy as an analgesic, spasmolytic, carminative, choleretic, disinfectant, and deodorizing agent.

ICD codes

Open the list of ICD codes

ICD-10 code	Indication
K81.1	Chronic cholecystitis
K82.8	Other specified diseases of gallbladder and cystic duct (including dyskinesia)
K83.0	Cholangitis
R07.2	Pain in the heart region
R10.4	Other and unspecified abdominal pain (colic)
R14	Flatulence and related conditions (including abdominal bloating, belching)
R51	Headache
R52.0	Acute pain
R52.2	Other chronic pain

ICD-11 code	Indication
8A8Z	Headache disorders, unspecified
DC12.1	Chronic cholecystitis
DC13	Cholangitis
DC1Z	Diseases of gallbladder and biliary tract, unspecified
DD93.1	Infantile colic
DD94	Functional disorder of the gallbladder
MC86	Precordial pain
MD81.4	Other and unspecified abdominal pain
ME08	Flatulence and related conditions
MG30.Z	Chronic pain syndrome, unspecified
MG31.Z	Acute pain, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

For oral administration. Swallow tablets whole with a sufficient amount of water. Do not crush or chew the tablets to preserve the enteric coating and prevent premature release of the active substance.

Take one to two tablets two to three times daily. Adhere to a consistent dosing schedule, preferably between meals.

Do not exceed the maximum daily dose of six tablets. The duration of treatment depends on the indication and clinical response; do not use for prolonged periods without medical consultation.

For relief of abdominal pain or flatulence, use as needed. For chronic conditions like cholecystitis or biliary dyskinesia, use as part of a longer-term regimen as directed by a physician.

Discontinue use and consult a physician if symptoms persist or worsen after several days of therapy. In patients with known cholelithiasis, use oral preparations with caution and only under medical supervision.

Adverse Reactions

Possible allergic reactions, irritation of the oral mucosa.

Contraindications

Hypersensitivity to peppermint, inflammatory diseases of the oral mucosa.

Use in Pregnancy and Lactation

During pregnancy and breastfeeding, it should be used after consultation with a doctor, in cases where the intended benefit to the mother outweighs the potential risk to the fetus or infant.

Pediatric Use

It can be used in children according to indications, in age-appropriate recommended doses and dosage forms. It is necessary to strictly follow the instructions in the leaflets of peppermint oil preparations regarding contraindications for the use of specific dosage forms of peppermint oil in children of different ages.

Special Precautions

In patients with cholelithiasis, drugs containing Peppermint oil intended for oral administration should be used with caution.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Mentha Piperitae tablets [Atoll LLC (Russia)]
Sublingual tablets 2.5 mg: 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 pcs.

Marketing Authorization Holder

Atoll LLC (Russia)

Manufactured By

Ozon, LLC (Russia)

Dosage Form

Mentha Piperitae tablets

Sublingual tablets 2.5 mg: 10, 20, 30, 40, 50, 60, 70, 80, 90, or 100 pcs.

Dosage Form, Packaging, and Composition

Sublingual tablets white or almost white, round, flat-cylindrical, slight marbling is allowed, with a characteristic odor, with a score line and a bevel.

	1 tab.
Peppermint leaf oil	2.5 mg

Excipients: sucrose – 391.5 mg, colloidal silicon dioxide – 2 mg, magnesium stearate – 4 mg.

10 pcs. – contour cell packs (1) – cardboard packs.
10 pcs. – contour cell packs (2) – cardboard packs.
10 pcs. – contour cell packs (3) – cardboard packs.
10 pcs. – contour cell packs (4) – cardboard packs.
10 pcs. – contour cell packs (5) – cardboard packs.
10 pcs. – contour cell packs (6) – cardboard packs.
10 pcs. – contour cell packs (7) – cardboard packs.
10 pcs. – contour cell packs (8) – cardboard packs.
10 pcs. – contour cell packs (9) – cardboard packs.
10 pcs. – contour cell packs (10) – cardboard packs.
10 pcs. – polymer jars (1) – cardboard packs.
20 pcs. – polymer jars (1) – cardboard packs.
30 pcs. – polymer jars (1) – cardboard packs.
40 pcs. – polymer jars (1) – cardboard packs.
50 pcs. – polymer jars (1) – cardboard packs.
60 pcs. – polymer jars (1) – cardboard packs.
70 pcs. – polymer jars (1) – cardboard packs.
80 pcs. – polymer jars (1) – cardboard packs.
90 pcs. – polymer jars (1) – cardboard packs.
100 pcs. – polymer jars (1) – cardboard packs.

Mentha Piperitae tablets [Vifitech, CJSC (Russia)]
Sublingual tablets 2.5 mg: 10, 20, 30, or 50 pcs.

Marketing Authorization Holder

Vifitech, CJSC (Russia)

Dosage Form

Mentha Piperitae tablets

Sublingual tablets 2.5 mg: 10, 20, 30, or 50 pcs.

Dosage Form, Packaging, and Composition

Sublingual tablets white, flat-cylindrical in shape, with a bevel and a score line, with a characteristic odor.

	1 tab.
Peppermint oil (peppermint leaf oil)	2.5 mg

Excipients: sucrose – 591.7 mg, talc – 2.9 mg, calcium stearate – 2.9 mg.

Mentha Piperitae tablets [Moscow Pharmaceutical Factory CJS (Russia)]
Sublingual tablets 2.5 mg: 10 or 20 pcs.

Marketing Authorization Holder

Moscow Pharmaceutical Factory CJS (Russia)

Dosage Form

Mentha Piperitae tablets

Sublingual tablets 2.5 mg: 10 or 20 pcs.

Dosage Form, Packaging, and Composition

Sublingual tablets white, slightly marbled, with the odor of peppermint oil, round, flat-cylindrical in shape with a bevel on both sides and a score line on one side.